Amgen Inc(AMGN)
264.75
Change: -6.12 (▼ -2.31%)
As of Wed 12/21/2022 12:52 AM% Of Value
Growth
Value Per Share
:
:
:
235.48
2.18
82.9100 (as of 20/12/2022)
Fundamentals Data
| Open | 266.69 | Dividend | 754 |
| Close Price | 264.75 | DivYield | 2.32 % |
| High | 267.68 | Growth | 555.0 M |
| Low | 262.82 | Growth% | 2.18 |
| P/e | 14.01 | Volume | 1.4 M |
| P/b | 9.77 | Market Capital | 152.9 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 272.40 (as of 20/12/2022) | 50 Days Moving Average Percentage | -2.5199096725631 (as of 20/12/2022 |
| Industry: Biotechnology: Biological Products (No Diagnostic Substances) |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 22.8 B | 23.7 B | 23.3 B | 25.4 B | 25.9 B |
| Cap Spending | -653.0 M | -738.0 M | -618.0 M | -608.0 M | -880.0 M |
| Operating Expenses | 8.8 B | 9.3 B | 9.3 B | 10.1 B | 11.8 B |
| Operating Cash Flow | 9.9 B | 10.2 B | 9.6 B | 9.1 B | 7.6 B |
| Free Cash Flow | 10.5 B | 10.5 B | 8.5 B | 9.8 B | 8.3 B |
| Free Cash Flow Per Share | 14.397 | 15.973 | 14.102 | 16.875 | 14.704 |
| Total liabilities | 35.3 B | 33.9 B | 29.9 B | 32.9 B | 33.3 B |
| Total cash | 3.8 B | 6.9 B | 6.0 B | 6.2 B | 7.9 B |
| ROE% | 0.066 | 0.585 | 0.743 | 0.717 | 0.725 |
| Outstanding Shares | 720.5 M | 622.2 M | 589.8 M | 577.5 M | 557.0 M |
| P/E | 64.06 | 14.01 | 17.073 | 18.816 | 21.047 |
| P/S | 5.548 | 4.952 | 5.731 | 5.376 | 4.774 |
| Revenue USD | 22.8 B | 23.7 B | 23.3 B | 25.4 B | 25.9 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|